SCHEMBL32688403

SCHEMBL32688403

N#Cc1c(N2CCN(c3ccccc3)CC2)nc(SCc2nnn[nH]2)[nH]c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR2 P25025 3/20 0.44
▸ ACMSD Q8TDX5 2/20 0.44
▸ POLB P06746 6/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ BRD4 O60885 1/20 0.43
▸ HSD11B1 P28845 1/20 0.43
▸ RAPGEF4 Q8WZA2 1/20 0.42
▸ HPGD P15428 4/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ TNF P01375 1/20 0.41
▸ PLA2G1B P04054 1/20 0.41
▸ NOD2 Q9HC29 1/20 0.41
▸ NOD1 Q9Y239 1/20 0.41
▸ ATG4B Q9Y4P1 1/20 0.41
▸ MAPT P10636 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688259 0.83 KDM4E (0.42) CXCR2ACMSDPOLBMEN1KMT2A
SCHEMBL32688041 0.79 ALDH1A1 (0.41) CXCR2ACMSDPOLBMEN1KMT2A
SCHEMBL24087923 0.77 ACMSD (0.53) CXCR2ACMSDPOLBMEN1KMT2A
SCHEMBL32688199 0.75 HSD11B1 (0.36) CXCR2POLBMEN1KMT2AHSD11B1
SCHEMBL32688224 0.73 ALDH1A1 (0.53) POLBKMT2AHPGDALDH1A1SMN1; SMN2
SCHEMBL23852241 0.72 MEN1 (0.69) CXCR2ACMSDPOLBMEN1KMT2A
SCHEMBL32688450 0.72 HSD11B1 (0.37) HSD11B1HPGDALDH1A1SMN1; SMN2NPSR1
SCHEMBL32688066 0.72 RET (0.40) HSD11B1
SCHEMBL24087918 0.70 MEN1 (0.47) CXCR2ACMSDPOLBMEN1KMT2A
SCHEMBL6949420 0.68 DAO (0.40) CXCR2ACMSDPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK CXCR2 2082/4885ACMSD 142/4885POLB 508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback